Malaria chemoprevention and drug resistance: a review of the literature and policy implications
CV Plowe - Malaria Journal, 2022 - Springer
Chemoprevention strategies reduce malaria disease and death, but the efficacy of anti-
malarial drugs used for chemoprevention is perennially threatened by drug resistance. This …
malarial drugs used for chemoprevention is perennially threatened by drug resistance. This …
[HTML][HTML] Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
M Ouji, JM Augereau, L Paloque, F Benoit-Vical - Parasite, 2018 - ncbi.nlm.nih.gov
The use of artemisinin-based combination therapies (ACTs), which combine an artemisinin
derivative with a partner drug, in the treatment of uncomplicated malaria has largely been …
derivative with a partner drug, in the treatment of uncomplicated malaria has largely been …
Antimalarial drug resistance and implications for the WHO global technical strategy
Abstract Purpose of Review Five years have passed since the World Health Organization
released its Global Technical Strategy for Malaria (GTS). In that time, progress against …
released its Global Technical Strategy for Malaria (GTS). In that time, progress against …
The COVID-19 pandemic: A threat to antimicrobial resistance containment
RC Founou, AJ Blocker, M Noubom, C Tsayem… - Future Science …, 2021 - Taylor & Francis
As of 23 April 2021, the outbreak of COVID-19 claimed around 150 million confirmed cases
with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of …
with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of …
Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in …
In Tanzania, chloroquine was replaced by sulphadoxine-pyrimethamine (SP) as a first-line
for treatment of uncomplicated malaria. Due to high resistance in malaria parasites, SP …
for treatment of uncomplicated malaria. Due to high resistance in malaria parasites, SP …
[HTML][HTML] Fighting COVID-19 at the expense of malaria in Africa: the consequences and policy options
Malaria remains a major global health burden, killing hundreds of thousands annually,
especially in sub-Saharan Africa. In December 2019, a novel illness termed COVID-19 …
especially in sub-Saharan Africa. In December 2019, a novel illness termed COVID-19 …
The genomic architecture of antimalarial drug resistance
AN Cowell, EA Winzeler - Briefings in functional genomics, 2019 - academic.oup.com
Plasmodium falciparum and Plasmodium vivax, the two protozoan parasite species that
cause the majority of cases of human malaria, have developed resistance to nearly all …
cause the majority of cases of human malaria, have developed resistance to nearly all …
Pausing the fight against malaria to combat the COVID-19 pandemic in Africa: is the future of malaria bleak?
Malaria remains a major global health burden, killing hundreds of thousands annually,
especially in sub-Saharan Africa. In 2019, a Phase IV Expanded Programme on …
especially in sub-Saharan Africa. In 2019, a Phase IV Expanded Programme on …
Chloroquine and sulfadoxine–pyrimethamine resistance in Sub-Saharan Africa—A review
Malaria is a great concern for global health and accounts for a large amount of morbidity and
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …
mortality, particularly in Africa, with sub-Saharan Africa carrying the greatest burden of the …
Plasmodium genomics: an approach for learning about and ending human malaria
JA Garrido-Cardenas, L González-Cerón… - Parasitology …, 2019 - Springer
Malaria causes high levels of morbidity and mortality in human beings worldwide. According
to the World Health Organization (WHO), about half a million people die of this disease each …
to the World Health Organization (WHO), about half a million people die of this disease each …